Predicting bleeding risk in blood cancer patients
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at a new way to predict if patients with blood cancers and very low platelets will have bleeding problems. By doing extra blood tests, researchers hope to create a score that helps doctors prevent bleeds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have a blood cancer or a bone marrow failure condition.
- Your platelet count is below 20 on a recent blood test (within the last 72 hours), and you haven't had a blood transfusion since that test.
- You are either admitted to a hospital or day unit, or being followed in an outpatient clinic.
- You have not taken certain blood-thinning medications (like aspirin, warfarin, or heparin) or specific targeted therapies (like ibrutinib) in the recent timeframes specified.
- You are not pregnant or breastfeeding, and you are able to understand French.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether umbilical cord blood can help raise platelet levels in people whose platelets drop after cancer treatment. If it works, it might reduce the need for platelet transfusions and lower bleeding risk.
This trial studies how best to prevent and treat dangerous blood clots in people with cancer who also have very low platelets. It may help guide safer blood-thinner treatment when bleeding risk is high.
This study looks at platelet transfusions—how they’re used and whether platelets function well—for people with blood cancers who have low platelet counts. It may help improve transfusion care for people who need platelet support.
This study tests if the blood thinner apixaban is safe and effective for cancer patients who have low platelets and a recent blood clot. It may offer a treatment option for those who cannot take standard blood thinners.
This trial tests if a medication called etamsylate can help prevent bleeding in patients getting a stem cell transplant. If your platelet count drops very low after transplant, this drug may reduce your risk of bleeding.
This trial tests how well platelet transfusions work for patients with blood cancers or bone marrow failure who have very low platelets and need a transfusion. It aims to see if the transfusions help control bleeding and improve outcomes.
Hear when a new Thrombocytopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.